G Tyden
Overview
Explore the profile of G Tyden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
239
Citations
1022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krmar R, Sandberg J, Ghahramani L, Sikorska W, Dahmane N, Svensson A, et al.
J Hum Hypertens
. 2012 Oct;
27(5):340-2.
PMID: 23034578
No abstract available.
2.
Tyden G, Mjornstedt L, Ekberg H, Tufveson G
Am J Transplant
. 2010 Jul;
10(8):1949.
PMID: 20659100
No abstract available.
3.
Gjertsen H, Sandberg A, Wadstrom J, Tyden G, Ericzon B
Transplant Proc
. 2006 Nov;
38(8):2644-5.
PMID: 17098026
Living donor kidney transplantation accounts for about 50% of the total number of renal transplantations at our center. From 1999 through 2005, 75 out of 220 living donor nephrectomies were...
4.
Genberg H, Hansson A, Wernerson A, Wennberg L, Tyden G
Am J Transplant
. 2006 Aug;
6(10):2418-28.
PMID: 16925569
The anti-CD20 antibody rituximab has recently gained interest as a B-cell depleting agent in renal transplantation. However, little is known about the pharmacodynamics of rituximab in renal transplant recipients. We...
5.
Genberg H, Kumlien G, Shanwell A, Tyden G
Transplant Proc
. 2005 Nov;
37(8):3288-9.
PMID: 16298575
Introduction: Acute rejection episodes still occur in spite of modern immunosuppressive protocols. We present seven patients with biopsy-proven acute rejections after kidney transplantation refractory to repeated pulses of high-dose steroids...
6.
Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I
Transplant Proc
. 2005 Nov;
37(8):3286-7.
PMID: 16298574
We have designed a protocol for ABO-incompatible kidney transplantations based on antigen-specific immunoadsorption rather than plasmapheresis to remove anti-A or anti-B antibodies and with a Prograf/Cellcept/prednisolone protocol using rituximab rather...
7.
Malaise J, Secchi A, Caldara R, Tyden G, Sandberg J, van Ophem D, et al.
Transplant Proc
. 2005 Sep;
37(6):2851-2.
PMID: 16182831
Unlabelled: Simultaneous pancreas-kidney (SPK) transplantation has become a standard therapy for patients with type 1 diabetes and end-stage renal disease. We analyzed metabolic data in this clinical setting under tacrolimus-...
8.
Tyden G, Sandberg J, Elinder C, Berg U
Transplant Proc
. 2003 Mar;
35(2):792-3.
PMID: 12644140
No abstract available.
9.
Filler G, Trompeter R, Webb N, Watson A, Milford D, Tyden G, et al.
Transplant Proc
. 2002 Aug;
34(5):1935-8.
PMID: 12176634
No abstract available.
10.
Fehrman-Ekholm I, Duner F, Brink B, Tyden G, Elinder C
Transplantation
. 2001 Aug;
72(3):444-9.
PMID: 11502974
Background: There is a lack of kidneys available for kidney transplantation, and living donors are increasingly used. It is important to examine the possible long-term adverse affect on the renal...